2026 ASCO Breast Cancer Highlights: HER2CLIMB-05 - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

2026 ASCO Breast Cancer Highlights: HER2CLIMB-05

Harold Burstein, MD, PhD, and Adrienne Waks, MD discuss the HER2Climb-05 trial and how it impacts treatment for HER2+ metastatic breast cancer

  • October 15, 2026

Share

Original Source(s)

2026 ASCO Breast Cancer Highlights: HER2CLIMB-05

  • October 15, 2026

Related Content

Screening strategies for the early detection of non-cardia gastric cancer in low- to moderate-prevalence regions: Asia-Pacific gastroesophageal cancer congress consensus 2026

GLP-1 Receptor Agonist Use Among Adults With Diabetes and Cancer History

Survival Outcomes With Lu-177 PSMA by Treatment Line and Taxane Sequencing in Prostate Cancer